Stay updated on Etrasimod in Ulcerative Colitis Clinical Trial
Sign up to get notified when there's something new on the Etrasimod in Ulcerative Colitis Clinical Trial page.

Latest updates to the Etrasimod in Ulcerative Colitis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAdds a top-level Locations section with listed sites (Alabama, California, Florida, Illinois, Michigan, New York, North Carolina, Ohio, Pennsylvania, Tennessee, Texas, Utah, Virginia, Washington, Wisconsin, Manitoba, Nova Scotia, Ontario). Removes individual location subsections (e.g., Alabama Locations, California Locations, etc.) and the HHS Vulnerability Disclosure link.SummaryDifference0.9%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedThe revision label changed from v3.3.1 to v3.3.2, with no changes to study content, eligibility criteria, or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check37 days agoChange DetectedThe Publications section now notes that items are auto-filled from PubMed, and the revision tag was updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page no longer displays the government funding status notice. Study details, enrollment, and listed locations remain unchanged.SummaryDifference0.2%

- Check58 days agoChange DetectedNo additions or deletions were detected on the Study Details page for NCT02447302; the content appears unchanged.SummaryDifference0.2%

- Check87 days agoChange DetectedUpdated operating-status notice and upgraded version from v3.0.2 to v3.2.0.SummaryDifference3%

Stay in the know with updates to Etrasimod in Ulcerative Colitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Etrasimod in Ulcerative Colitis Clinical Trial page.